Research powered investment banking
Home
Research
Companies
Find Alpha
Themes
Top Picks
Premium
Transactions
Events
Redeye
At a Glance
Our Culture
Investor Services
Corporate Broking
Certified Adviser
Corporate Finance
Newsroom
The Team
Careers
FAQ
Governance
Members network
Community
sign in
Home
research
Companies
Find Alpha
Themes
Top Picks
Transactions
Events
redeye
About
At a Glance
Our Culture
Investor Services
Corporate Broking
Certified Adviser
Corporate Finance
Newsroom
The Team
Careers
FAQ
Governance
Community
Company overview

Remedy: The countdown begins

Redeye Research Update timeStamp 2019/08/19

In about one week (August 27), Remedy will release in many ways its most ambitious project yet namely the game “Control”. Previews of the game tell us that Control will be a weird and very original experience with both an engaging story and fun gameplay. The indicated quality of the game from critics make us believe the game has a good chance of exceeding our sales estimates. A favorable release window and a promised significant visibility on Playstation marketing channels and the Epic Games Store strengthens the case further. However, a fairly niched product can dampen sales according to us. We have done some changes in our estimates.

Download research report

Tomas Otterbeck

Equity Analyst

Kristoffer Lindström

Equity Analyst

Does Remedy Entertainment have great people behind it? Find out now:
Visit Stock Insight
Tagged companies
  • Office
  • Mäster Samuelsgatan 42, 10th floor
  • Box 7141, 103 87
  • Stockholm, Sweden
  • info@redeye.se
  • +46 (0)8 545 013 30
  • Services
  • Home
  • Research
  • Transactions
  • Events
  • Redeye
  • Community
  • Members Home
  • Premium
  • Legal
  • Terms and conditions (Swedish)
  • Terms of membership (Swedish)
  • Terms and conditions - Advisory (Swedish)
  • Terms and conditions - Advisory (English)
  • Integrity Policy (Swedish)
  • Disclaimer (Swedish)
  • Governance
  • Follow
  • Twitter
  • Facebook
  • LinkedIn
  • Redeye
  • At a Glance
  • Our Culture
  • Investor Services
  • Corporate Broking
  • Corporate Finance
  • Newsroom
  • The Team
  • Careers
  • FAQ

© All rights reserved. Redeye AB is authorised and regulated by the Swedish Financial Supervisory Authority, Finansinspektionen. 2017

You need to be a Redeye member to access this content

Become a member to:

  • Access all our extensive research on 100+ Nordic Tech and Life Science companies
  • Make smarter investment decisions with the guidance of our experienced analysts
  • Receive exciting offers to participate in IPO’s and other transactions

    By clicking "Sign up" you indicate that you read and agree to our Terms & Conditions

    I already have an account and want to sign in